Items tagged with Medicines
Gates Foundation, SA link to combat HIV, TB, malaria (post)
The Bill and Melinda Gates Foundation has partnered with SA institutions to develop new medicines and vaccines for HIV, TB and malaria.
Promising class of antibiotics discovered for treatment of drug-resistant tuberculosis (post)
Research led by St. Jude Children’s Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance
Critical Path Institute receives grant to accelerate development of TB treatments (post)
TUCSON, Ariz., Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute, an independent, non-profit that catalyzes innovative ideas that accelerate the speed of drug and medical product development, today announced it has received a three-year grant from the Bill & Melinda Gates Foundation. The grant will be used to develop quantitative mathematical models to optimize the design of clinical trials and tackle challenges facing the development of effective tuberculosis (TB) treatments.
IDWeek: Some progress in TB drug and diagnostic development, but not enough (post)
The emerging crisis of multidrug-resistant tuberculosis is a “personal and health system catastrophe” that’s occurring half a million times a year in the form of new cases, Eric Nuermberger said at an IDWeek session on HIV-related opportunistic diseases. Not only is it an intensively difficult disease to treat, requiring up to two years of therapy with very toxic and expensive drugs with poor efficacy, “we continue to learn it’s even worse than we may have first thought,” he said.
ORCHID project aims to slash development time of tuberculosis drugs (post)
A collaborative project led by a scientist from UK pharma major GSK (LSE: GSK) has identified new compounds for the fight against TB.
Problems giving current second line TB drugs to children (post)
Results from a survey presented at 45th Union World Conference on Lung Health reveal an urgent need for child appropriate formulations of second line TB drugs. 
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children (post)
Australia grants support for TB Alliance to advance new TB drugs (post)
TB Alliance, a not-for-profit product development partnership with the mission of developing better, faster, and affordable drugs for tuberculosis (TB), has received a grant from the Australian Department of Foreign Affairs and Trade (DFAT) to support late-stage clinical trials of new TB treatments. The grant was announced at a World TB Day event in Canberra, Australia as part of a larger investment of support for new tools to tackle diseases that endanger public health in the region.
Khayelitsha clinic leads the way for new TB drug (post)
Drug-resistant tuberculosis is a major health challenge across much of Africa, but a new medicine being pioneered in South Africa could be a breakthrough after decades of frustration.
WHO opens its database of medicines side effects to the public (post)
The World Health Organization has announced that its Global Medicines Safety Database is now open to the general public. The database named VigiAccess can now be accessed on any computer or smartphone in the world.
Page 1 of 18 · Total posts: 01 2 Last→